Literature DB >> 2554913

In vitro effect of eicosapentaenoic and docosahexaenoic acids on prostaglandin E2 synthesis in a human lung carcinoma.

R J de Antueno1, M G de Bravo, J Toledo, O Mercuri, M E De Tomás.   

Abstract

The capacity to synthesize both prostaglandins E1 (PGE1) and E2 (PGE2) has been determined in human lung mucoepidermoid carcinoma homogenates when [14C]-fatty acid precursors were added to the incubation medium. Only 10% of the total radioactivity recovered in PGs was found in PGF1 alpha and PGF2 alpha. The experiments were principally focused to inhibit the PGE2 synthesis either with pure eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids or with mixtures of both n-3 fatty acids obtained from fish oil. The results demonstrated that significant inhibitions were found when using 25 microM or a higher concentration of pure EPA or DHA in the incubation medium; however, 5 microM of mixtures of different EPA/DHA ratio caused the same inhibition. The results suggest that EPA and DHA, when added together, may enforce their inhibitory effect on PGE2 synthesis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2554913

Source DB:  PubMed          Journal:  Biochem Int        ISSN: 0158-5231


  3 in total

1.  Levels of thiobarbituric acid reactive substances and the cytocidal potential of gammalinolenic and docosahexaenoic acids on ZR-75-1 and CV-1 cells.

Authors:  M E Bégin; G Ells
Journal:  Lipids       Date:  1992-02       Impact factor: 1.880

2.  Effects of an eicosapentaenoic and docosahexaenoic acid concentrate on a human lung carcinoma grown in nude mice.

Authors:  M G de Bravo; R J de Antueno; J Toledo; M E De Tomás; O F Mercuri; C Quintans
Journal:  Lipids       Date:  1991-11       Impact factor: 1.880

3.  Chemoprevention of DMBA-induced mammary carcinogenesis in rats by low-dose EPA and DHA.

Authors:  M Noguchi; M Minami; R Yagasaki; K Kinoshita; M Earashi; H Kitagawa; T Taniya; I Miyazaki
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.